Latanoprost gel for vitiligo in teens
Part of Skin clinical trials.
This trial tests a gel called latanoprost for teens with stable vitiligo. It looks at whether the gel helps bring back color to white patches on the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-segmental vitiligo (white patches on both sides of your body).
- Your vitiligo has been stable (no new patches or growth) for at least 6 months.
- You are between 10 and 17 years old.
- Your vitiligo covers less than 10% of your body.
- You have at least two patches that are similar in size (1 to 4 square centimeters), one on each side of your body, and not on palms, soles, or genitals.
- You have not used certain creams, pills, or light therapy for vitiligo for at least 2 weeks (or 4 weeks for some) before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for vitiligo: narrowband UVB light therapy combined with either tacrolimus ointment or calcipotriol ointment. It aims to see which combination works better and is safer for people with stable, limited vitiligo.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This trial tests a new oral medication called ACT-777991 to see if it is safe and can help repigment skin in adults with non-segmental vitiligo (the most common type that affects both sides of the body). Participants must have at least a certain amount of pigment loss on the face and total body, and agree not to use other vitiligo treatments during the study.
This trial tests a cream (ruxolitinib) combined with corticosteroid treatment for people with active, non-segmental vitiligo that affects the face. It aims to see how well this combination works in real-world settings.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
Hear when a new Vitiligo - Macular Depigmentation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.